Business Context and Reporting Period
Company: KLA Instruments Corporation (KLA)
Reporting Period: Fiscal year ended June 30, 1994
Industry: Semiconductor yield management and process monitoring systems.
KLA is the world's largest supplier to the wafer, reticle, and metrology inspection equipment markets. The company provides systems that analyze product and process quality to help semiconductor manufacturers increase yields. Key business units include WISARD (wafer inspection), RAPID (reticle inspection), Metrology (overlay and critical dimension measurement), ATS (wafer probers), and PRISM (software productivity systems).
Key Financial Metrics
Revenue, Profit, Cash Flow, and Margins: The filing text incorporates the Consolidated Statement of Operations, Balance Sheet, and Cash Flows by reference to the 1994 Annual Report to Stockholders. Specific numerical values for total revenue, net income, operating cash flow, and profit margins are not explicitly stated in the provided text.
Research and Development (R&D): R&D expense was 9% of sales for fiscal 1994 (down from 10% in 1993 and 17% in 1992). This figure is net of external funding and capitalization, which accounted for approximately 2% of sales in 1994.
Backlog: $125 million as of June 30, 1994, with 99% shippable within one year.
Debt and Liquidity:
- Short-term Borrowings: $4.673 million outstanding at June 30, 1994.
- Weighted Average Interest Rate: 4.10% at period end.
- Credit Facilities: Includes a $10 million multicurrency line of credit.
- Allowance for Doubtful Accounts: $1.754 million at June 30, 1994.
Market Data: As of August 31, 1994, the aggregate market value of voting stock held by non-affiliates was approximately $994.2 million. There were 22,974,230 shares of Common Stock outstanding.
Material Changes vs. Prior Period
- Backlog Growth: Backlog increased significantly from $52 million in fiscal 1993 to $125 million in fiscal 1994.
- R&D Efficiency: R&D expense as a percentage of sales decreased to 9% in 1994, compared to 10% in 1993 and 17% in 1992.
- Product Delays: The RAPID business unit experienced a decline in fiscal 1993 and 1994 due to delays in completing features for the new KLA 331 reticle inspection system, causing customers to defer orders.
- Customer Concentration: No single customer accounted for more than 10% of revenues in fiscal 1994 (Motorola accounted for approximately 11% in fiscal 1993).
- Debt Levels: Short-term borrowings at period end were $4.673 million in 1994, compared to $2.532 million in 1993.
Guidance, Outlook, and Risks
Outlook and Strategy: Management expects the market for in-line monitoring systems to be several times larger than the traditional engineering analysis market. The company is expanding its San Jose campus and planning construction of additional buildings to meet demand. Capital expenditures for fiscal 1995 are expected to approximate depreciation unless demand exceeds estimates.
Legal Proceedings and Contingencies:
- Orbot Systems Litigation: KLA is involved in patent infringement lawsuits against Orbot Systems Ltd. (Orbotech). Management believes the outcome will not have a significant adverse effect.
- Lemelson Patent Suit: KLA may be liable as a potential indemnitor if Jerome Lemelson prevails in his patent infringement suit against other semiconductor companies (e.g., Motorola).
- PCB Business Discontinuation: KLA is a defendant in three suits related to the discontinuance of its printed circuit inspection business; management does not expect significant adverse effects.
Risks:
- Competition: The market is highly competitive with rapid technological obsolescence. Competitors may introduce superior price/performance products.
- Supply Chain: Dependence on single or limited source suppliers for certain components could temporarily adversely affect operations if supply is interrupted.
- Intellectual Property: Protection of patents and trade secrets is critical but may be limited in certain foreign countries.
Investor Verification Checklist
- Verify the specific revenue and net income figures for fiscal 1994 in the incorporated 1994 Annual Report to Stockholders (pages 14-24), as they are not listed in the 10-K text.
- Confirm the status of the KLA 331 reticle inspection system delays and their impact on the RAPID division's revenue recovery.
- Review the details of the $10 million multicurrency line of credit and any covenants associated with the Bank of America credit agreements.
- Monitor the progress of the patent litigation against Orbot and the potential indemnity exposure related to the Jerome Lemelson lawsuit.
- Assess the timeline for the construction of new facilities in San Jose and the associated capital expenditure requirements.